 | |
| Consortium overview | |
|---|---|
| Formed | December 30, 2020; 4 years ago (2020-12-30) |
| Type | Consortium underGovernment of India |
| Status | Active |
| Parent department | Department of Biotechnology |
| Website | dbtindia.gov.in/insacog |
INSACOG (Indian SARS-CoV-2 Consortium on Genomics[1] or Indian SARS-CoV-2 Genetics Consortium[2]) is the forum set up under theMinistry of Health and Family Welfare by theGovernment of India on 30 December 2020, to study and monitor genome sequencing and virus variation of circulating strains ofCOVID-19 in India.[1][2][3] Initially it was tasked to study the virus variantLineage B.1.1.7 earlier found inUnited Kingdom in December 2020.
INSACOG works as a consortium of 38[4] national laboratories for genome sequencing located in different parts ofIndia.[5] All these 10 laboratories are required to share 5% of positive samples to INSACOG for further research and studies. ANational Centre for Disease Control (NCDC) nodal unit maintain a database of all samples of the new variants. Two national genomic sequencing database centers are appointed 1)National Institute of Biomedical Genomics and 2)CSIR Institute of Genomics and Integrative Biology.[6] In its early research INSACOG identified virus variantLineage B.1.617 referred to as a double mutation variant.[7][8]
Though these mutations have individually been found in several other coronavirus variants, the presence of both these mutations together have been first found in some coronavirus genomes from India.
| |||||||||||||
| Topics |
| ||||||||||||
| Incidents | |||||||||||||
| Locations |
| ||||||||||||
| Legal framework | |||||||||||||
| Agencies and institutes |
| ||||||||||||
| Officials |
| ||||||||||||
.svg)